Unum Therapeutics - 48 Year Dividend Yield History | UMRX

Historical dividend payout and yield for Unum Therapeutics (UMRX) since 1971. The current TTM dividend payout for Unum Therapeutics (UMRX) as of February 15, 2019 is $0.00. The current dividend yield for Unum Therapeutics as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.129B $0.008B
Unum Therapeutics Inc. is a biopharmaceutical company. It focused on the development and commercialization of novel immunotherapy products of immune system to cure cancer. The company's program consists of ACTR087 rituximab, ACTR707 RITUXIMAB, ACTR087 SEA-BCMA which are in clinical stage. Unum Therapeutics Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76